vTv Therapeutics
VTVT
$27.90
Share price
0.07%
Change (1 day)
2,900.00%
Change (1 year)
Categories
vTv Therapeutics (VTVT) - P/B ratio
P/B ratio as of May 2024 : -3.66
According to vTv Therapeutics
's latest financial reports the company has a price-to-book ratio of -3.66.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
vTv Therapeutics - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -1.26 | -113.65% |
| 2022-12-31 | 9.25 | 111.38% |
| 2021-12-31 | 4.38 | -348.76% |
| 2020-12-31 | -1.76 | -20.76% |
| 2019-12-31 | -2.22 | 59.76% |
| 2018-12-31 | -1.39 | 6.42% |
| 2017-12-31 | -1.31 | -25.08% |
| 2016-12-31 | -1.74 | -39.19% |
| 2015-12-31 | -2.87 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -117.84% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -153.57% | 🇺🇸 USA |